Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epoetin beta 100,000unit inj vials
0901030E0AAAMAM
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin beta 20,000unit inj pre-filled disposable devices
0901030E0AAAJAJ
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin beta 50,000unit inj vials
0901030E0AAAKAK
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin beta 60,000unit inj pre-filled disposable devices
0901030E0AAAWAW
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin delta 1,000units/0.5ml inj pre-filled syringes
0901030L0AAAAAA
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 10,000units/0.5ml inj pre-filled syringes
0901030L0AAAHAH
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 2,000units/0.5ml inj pre-filled syringes
0901030L0AAABAB
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 3,000units/0.3ml inj pre-filled syringes
0901030L0AAACAC
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 4,000units/0.4ml inj pre-filled syringes
0901030L0AAADAD
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 5,000units/0.5ml inj pre-filled syringes
0901030L0AAAEAE
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 6,000units/0.3ml inj pre-filled syringes
0901030L0AAAFAF
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 8,000units/0.4ml inj pre-filled syringes
0901030L0AAAGAG
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin theta 1,000units/0.5ml inj pre-filled syringes
0901030S0AAAAAA
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 10,000units/1ml inj pre-filled syringes
0901030S0AAAFAF
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 2,000units/0.5ml inj pre-filled syringes
0901030S0AAABAB
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 20,000units/1ml inj pre-filled syringes
0901030S0AAAGAG
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 3,000units/0.5ml inj pre-filled syringes
0901030S0AAACAC
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 30,000units/1ml inj pre-filled syringes
0901030S0AAAHAH
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 4,000units/0.5ml inj pre-filled syringes
0901030S0AAADAD
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 5,000units/0.5ml inj pre-filled syringes
0901030S0AAAEAE
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin zeta 1,000units/0.3ml inj pre-filled syringes
0901030Q0AAAAAA
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 10,000units/1ml inj pre-filled syringes
0901030Q0AAAHAH
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 2,000units/0.6ml inj pre-filled syringes
0901030Q0AAABAB
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 20,000units/0.5ml inj pre-filled syringes
0901030Q0AAAJAJ
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 3,000units/0.9ml inj pre-filled syringes
0901030Q0AAACAC
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.